Joel Salinas, MD, is an author on a study that, using data from the Framingham Heart Study, revealed that a particular whole blood microRNA (miR-574-3p) expression was significantly lower in participants with chronic stroke, signaling the need for further research aimed at developing better diagnostic and treatment options for cerebrovascular disease.
Longitudinal study finds link between whole blood microRNAs and stroke
